Skip to main navigation

albireo_logo_nav.svg

  • About
    • Overview
    • Enterprise Team
    • Board of Directors
    • Partnering
    • Contact
  • Programs & Science
    • Bile Acids and IBAT Inhibition
    • Pipeline
    • Odevixibat
    • A3384
    • Elobixibat
  • Patients & Families
    • Progressive Familial Intrahepatic Cholestasis (PFIC)
    • ALAGILLE SYNDROME
    • BILIARY ATRESIA
    • Chronic (Idiopathic) Constipation
    • ADULT LIVER DISEASES
    • Bile Acid Malabsorption (BAM)
    • Clinical Trials
    • Expanded Use
  • Media & Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Publications
    • 2020 Annual Meeting
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • Careers
    • Current Openings

Events & Presentations

Financials menu

  • Financials & Filings

Stock Information menu

  • Stock Information

governance menu

  • Corporate Governance

Upcoming Events

Virtual Investor Commercial Day 2021
Feb 11, 2021 at 11:30 AM EST
Listen to webcast
Add to Outlook
Add to Google Calendar

Please click here to be notified of all upcoming events.

Archived Events

2019 Wedbush Healthcare Conference
Aug 13, 2019 at 8:35 AM EDT
Listen to webcast
Albireo Provides Second Quarter 2019 Business Update
Aug 8, 2019 at 10:00 AM EDT
Listen to webcast

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3

Shareholder Tools

  • Email Alerts

    Email Alerts

  • RSS

    RSS

  • Print

    Print

 
albireo-white

© 2018 Albireo Pharma, Inc.

Contact |  Terms of Use  |  Privacy Policy      twitter